| Literature DB >> 29581873 |
Abstract
Nostoc commune Vaucher, a macroscopic cyanobacterium, has long been appreciated as a healthy food and traditional medicine worldwide. Accumulated evidence has demonstrated that it possesses a wide range of remarkably protective physiological and pharmacological activities, largely based on animal and in vitro studies. In this review, we summarise and update evidence regarding the chemical composition and nutritional characteristics of Nostoc commune Vaucher, and comprehensively discuss the recent studies on the antioxidative, anti-inflammatory, anti-carcinogenic and immune regulation properties of Nostoc commune Vaucher and Nostoc commune Vaucher-derived extracts. The available results demonstrate the potential of it to act as a functional food for the amelioration of human associated diseases. More details from human clinical trials should be a matter of further investigation.Entities:
Keywords: Nostoc commune Vaucher; composition; functional food; human health
Year: 2017 PMID: 29581873 PMCID: PMC5865699 DOI: 10.18632/oncotarget.23620
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Nostoc commune Vaucher in nature (A) [1] and under dry condition (B).
Anti-inflammatory and antibacterial properties of N. commune
| Bioactives | Key effects | Ref. | |
|---|---|---|---|
| petroleum ether, acetylacetic ester, acetone, ethanol, carbinol & aqueous extracts | 1. Lower polar ethyl acetate and acetone extracts exhibited potent antibacterial activity against | [ | |
| methanol extracts | 1. Obvious inhibition growth of | [ | |
| 1. Significant antibacterial activity against | [ | ||
| fat-soluble compositions | 1. Inhibitory effects against six strains: | [ | |
| diterpenoid | Noscomin | 1. Antibacterial activity against | [ |
| Comnostins A-E | 1. Comnostin C had a MIC value for | [ | |
| diterpenoid | 1. Selective potent antibacterial activity against | [ | |
| anthraquinone | 1. Moderate antibacterial activity against | [ | |
| indane derivative | 1. Moderate antibacterial activity against | [ | |
| polysaccharides | 1. Dose dependent inhibited growth of | [ | |
| 1. Inhibition of the growth of | [ | ||
| 1. Potent antibacterial activity against | [ | ||
| total flavonoids | 1. Dose dependent antibacterial activity against | [ | |
| lipopeptide | Nostofungicidine | 1. Potent antifungal activity against | [ |
| heteroglycan | Nc-5-s | 1. Less secretion of IL-6 and more of IL-10 in LPS-stimulated human THP-1 monocytes. | [ |
| indole alkaloid | Reduced-scytonemin | 1. Suppression LPS/IFNγ-induced NO production in murine macrophage RAW264 cells by inducing HO-1 expression via the Nrf2/ARE pathway. | [ |
| b-ionone derivatives | Nostocionone and its derivatives, NostD3 | 1. Significant inhibition of | [ |
Abbreviations: PI3K, phosphoinositide 3-kinase; NO, nitric oxide; HO, hemeoxygenase; iNOS, inducible nitric oxide synthase.
Antioxidative properties of N. commune
| Bioactives | Key effects | Ref. | |
|---|---|---|---|
| polysaccharides | 1. O2·− scavenging capacity value was higher by 54.8% and 103.7%, respectively, compared to | [ | |
| 1. Increase the antioxidase activity in | [ | ||
| total flavonoids | 1. Higher antioxidative ability than those of polysaccharides and fat-soluble components. | [ | |
| glycosylated mycosporine-like amino acids (MAA) | 1050-Da MAA | 1. Approximate 27% contribution of the total radical scavenging activity in the water extract of | [ |
Anti-carcinogenic and Immunomodulating property of N. commune
| Bioactives | Model | Key effects | Ref. |
|---|---|---|---|
| Anti-carcinogenic property | |||
| crude extracts | A549, human lung epithelium adenocarcinoma | 1. Significant inhibition of cell proliferation with IC50 of 24.79 and 51.33 μg/mL, respectively. | [ |
| reduced-scytonemin | Human T-lymphoid cell line Jurkat cells | 1. Induction of autophagy by ROS formation | [ |
| synthesized Nostocionone derivative | Human T-lymphoid cell line Jurkat cells | 1. Potently inhibited cell growth more than Nostocionone. | [ |
| water stress proteins | DLD1, HCT-116, HT-29, and SW480, | 1. Inhibited cell proliferation with IC50 of 0.19 ± 0.02, 0.21 ± 0.03, 0.39 ± 0.05, and 0.41 ± 0.01μg/mL, respectively. | [ |
| BALB/c mice with subcutaneously implanted DLD1 cells | 1. Suppressed tumor after WSP1 treatment | [ | |
| DLD1, human colon carcinoma | 1. Increased cell-cell adhesion and reduced cell-matrix adhesion. | [ | |
| recombinant water stress proteins 1 | SW480, human colon carcinoma | 1. Significant suppression of cell growth. | [ |
| extracelluar polysaccharides | MCF-7, human breast cancer; | 1. Significant inhibited cell proliferation with IC50 of 67 and 110 μg/mL, respectively. | [ |
| NCI-H446 & NCI-H1688, human small cell lung | 1. Remarkable suppressed cell migration through blocking the EMT. | [ | |
| Immunomodulating property | |||
| oligosaccharides | Sheep erythrocytes | 1. Strong effect on the complement system by complement fixation test. | [ |
| polysaccharides-rich extract | Human peripheral blood-mononuclear cells; U937, human leukemia; Raw 264.7, murine | 1. Effective inhibited cell growth of U937. | [ |
Abbreviations: ROS, reactive oxygen species; Endo-G, endonuclease G; ERS, endoplasmic reticulum stress; EMT, epithelial-mesenchymal transition program; GM-CSF, granulocyte/macrophage-colony stimulatory factor; NO, nitric oxide.
Figure 2Schematic representation of N. commune and N. commune-derived extracts regulative properties on human health
Figure 3Chemical structures of common bioactive compounds from N. commune
(A) Structure of glycosylated mycosporine-like amino acids [17, 49]. (B) Structure of an antifungal lipopeptide [33]. (C) Structure of diterpenoid derivatives which is uncommon in cyanobacteria [23–25]. (D) Structure of a long chain fatty acid [18]. (E) Structure of oligosaccharides isolated after weak acid hydrolysis of the acidic polysaccharide [11]. (F) Structure of Nc-5-s, a complex heteroglycan, composed of repeating units of 1, 1a, 1b and 2 and 2a in molar ratio of (10:25:50:5:10) [13, 66]. (G) Structure of an indane derivative [25]. (H) Structure of indole alkaloids [7, 8, 27, 41]. (I) Structure of β-ionone derivatives [4, 27, 41]. (J) Structure of an anthraquinone derivative [25].